CAMP4 Therapeutics Corporation (CAMP) vs Entrada Therapeutics, Inc. (TRDA)
CAMP4 Therapeutics Corporation and Entrada Therapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Entrada Therapeutics, Inc. are of similar size ($242.2M and $241.0M). CAMP4 Therapeutics Corporation has the higher net margin (−2,543.7% vs −3,537.7%) and the higher return on invested capital (0.00% vs −1,060.2%). Across the 13 metrics below, CAMP4 Therapeutics Corporation leads on 8 and Entrada Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CAMP | TRDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (1,254.22%) | (3,767.07%) | 0.00% |
| Net margin | (2,543.74%) | (3,537.73%) | 0.00% |
| Free cash flow margin | (680.36%) | (2,867.07%) | 0.00% |
| Return on equity | (545.85%) | (54.09%) | (57.72%) |
| Return on assets | (148.23%) | (44.35%) | (49.22%) |
| Return on invested capital | 0.00% | (1,060.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack